Breathing-Related Sleep Disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), encompass a range of disorders characterized by abnormal breathing patterns during sleep. These disorders include Obstructive Sleep Apnea Hypopnea, Central Sleep Apnea, and Sleep-Related Hypoventilation. Individuals suffering from these conditions typically experience disruptions in sleep due to difficulties in breathing, which can lead to significant distress or impairment in social, occupational, or other important areas of functioning (American Psychiatric Association [APA], 2023).

Obstructive Sleep Apnea Hypopnea is marked by repeated episodes of upper airway collapse during sleep, leading to reduced or completely blocked airflow, despite ongoing breathing efforts. This results in frequent arousals from sleep and significant reductions in blood oxygen saturation. People with this disorder often present with loud snoring, observed episodes of breathing cessation during sleep, and excessive daytime sleepiness.

Central Sleep Apnea involves a decrease or stoppage in respiratory effort during sleep due to a lack of respiratory effort. It is less common than obstructive sleep apnea and is often associated with certain medical conditions, such as heart failure or stroke.

Sleep-Related Hypoventilation is characterized by decreased breathing during sleep, not due to airway blockages but rather a reduction in respiratory drive. This leads to elevated levels of carbon dioxide during sleep.

Regarding presentation, individuals with Breathing-Related Sleep Disorders may exhibit symptoms such as daytime fatigue, morning headaches, difficulty concentrating, mood disturbances, and impaired performance at work or school. They may be unaware of the breathing difficulties they experience during sleep, and it is often a bed partner or family member who first notices the signs.

The exact pathophysiology of these disorders varies, with factors such as obesity, anatomical abnormalities, neuromuscular disorders, and other medical conditions playing a role. Treatment typically involves addressing the underlying cause, and in the case of obstructive sleep apnea, may include the use of continuous positive airway pressure (CPAP) therapy, oral appliances, or surgery in some cases.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5-TR), categorizes Breathing-Related Sleep Disorders into several types, each with its specific diagnostic criteria. The primary types are Obstructive Sleep Apnea Hypopnea (OSAH), Central Sleep Apnea (CSA), and Sleep-Related Hypoventilation. These disorders are diagnosed based on clinical and polysomnographic evidence (APA, 2023).

Obstructive Sleep Apnea Hypopnea (OSAH): This is characterized by repeated episodes of obstruction of the upper airway during sleep, leading to decreased breathing (hypopnea) or complete pauses in breathing (apnea). The DSM-5-TR criteria for OSAH include:

• Evidence of at least five obstructive apneas or hypopneas per hour of sleep, accompanied by nocturnal breathing disturbances or daytime sleepiness, fatigue, or unrefreshing sleep.
• Alternatively, there is evidence of 15 or more obstructive apneas and hypopneas per hour of sleep, regardless of accompanying symptoms.

Peppard et al. (2013) highlighted the prevalence and public health impact of OSAH, indicating its association with cardiovascular diseases.

Central Sleep Apnea (CSA): CSA involves a lack of drive to breathe during sleep, resulting in repeated periods of insufficient ventilation and affecting blood oxygen levels. The DSM-5-TR outlines the following criteria:

• Evidence of five or more central apneas per hour of sleep.
• Another sleep disorder does not better explain these apneas.

A study by Javaheri et al. (2017) explored the pathophysiology and clinical impacts of CSA, particularly in the context of heart failure.

Sleep-Related Hypoventilation: This disorder is characterized by decreased breathing during sleep, leading to elevated blood carbon dioxide levels. The DSM-5-TR criteria include:

• Polysomnographic evidence of diminished ventilation leads to an increase in blood carbon dioxide levels during sleep.
• Another sleep disorder, mental disorder, medication, or substance use does not better explain hypoventilation.

Research by Mokhlesi & Kryger (2017) has delved into the clinical aspects and management strategies of sleep-related hypoventilation, emphasizing its correlation with obesity and other comorbid conditions. These diagnostic criteria rely heavily on polysomnography, a comprehensive sleep study that records brain waves, oxygen levels in the blood, heart rate, breathing, and eye and leg movements.

The DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) specifiers for Breathing-Related Sleep Disorders provide additional detail and characterization, helping clinicians better understand and treat the condition. These specifiers are particularly relevant for conditions such as Obstructive Sleep Apnea Hypopnea, Central Sleep Apnea, and Sleep-Related Hypoventilation. They typically focus on factors such as severity, etiology, and the presence of associated features or conditions.

• Severity Specifiers: The severity of breathing-related sleep disorders is often categorized based on the frequency of episodes and the degree of associated symptoms. For example, severity can be specified as mild, moderate, or severe in Obstructive Sleep Apnea Hypopnea, based on the Apnea-Hypopnea Index (AHI) - the number of apneas and hypopneas per hour of sleep.
• Etiological Specifiers: These specifiers relate to the underlying cause or associated conditions. For instance, Central Sleep Apnea can have specifiers indicating whether it is associated with a medical condition like heart failure, due to a medication or substance, or idiopathic (of unknown cause).
• With or Without Snoring: This specifier is particularly relevant for Obstructive Sleep Apnea Hypopnea, where snoring is a common symptom but not universally present.
• With or Without Associated Features: This can include associated features such as insomnia or daytime sleepiness, which are common in individuals with breathing-related sleep disorders.
• With Oxygen Desaturation: This specifier indicates the presence and extent of oxygen desaturation during sleep, a key feature in many breathing-related sleep disorders.

It's important to note that using these specifiers depends on the detailed clinical assessment and the results of sleep studies like polysomnography. These specifiers help tailor treatment plans and understand the potential risks and complications associated with the disorder.

The Impacts

Breathing-Related Sleep Disorders, as outlined in the DSM-5-TR, have significant impacts on both physical and mental health. The most common among these disorders is Obstructive Sleep Apnea Hypopnea (OSAH), which has been extensively studied for its wide-ranging effects.

Cardiovascular Impacts: OSAH is strongly associated with cardiovascular problems. A landmark study by Peppard et al. (2013) demonstrated a dose-response relationship between the severity of apnea and the risk of hypertension, heart failure, and other cardiovascular disorders. This study, which followed participants over several years, found that even moderate sleep apnea doubled the risk of developing hypertension.

Metabolic Effects: Breathing-related sleep disorders are also linked with metabolic syndromes. Drager et al. (2013) found that sleep apnea contributes to insulin resistance, glucose intolerance, and type 2 diabetes. This relationship is mediated by intermittent hypoxia and sleep fragmentation, which induce oxidative stress and inflammation.

Neurocognitive and Psychological Consequences: Sleep disruption from these disorders leads to significant neurocognitive and psychological consequences. Research by Beebe et al. (2016) found that untreated sleep apnea can result in memory impairments, executive dysfunction, and even mood disorders like depression and anxiety. These effects are thought to be due to the impact of chronic sleep disruption and hypoxemia on brain function.

Impact on Quality of Life: Patients with breathing-related sleep disorders often experience reduced quality of life. A study by Moyer et al. (2016) highlighted that chronic fatigue, daytime sleepiness, and snoring associated with these disorders adversely affect daily functioning, work productivity, and social relationships.

Mortality Risks: The long-term risks associated with untreated sleep apnea include increased mortality. A longitudinal study by Young et al. (2008) indicated that severe sleep apnea significantly increases the risk of death, independent of other risk factors such as obesity and age.

These studies underline the importance of recognizing, diagnosing, and effectively managing breathing-related sleep disorders to mitigate these adverse health outcomes.

The Etiology (Origins and Causes)

The etiology of Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), Central Sleep Apnea (CSA), and Sleep-Related Hypoventilation, involves a complex interplay of anatomical, physiological, and environmental factors.

Anatomical Factors in OSAH: Anatomical predispositions play a crucial role in the development of OSAH. Studies have shown that individuals with specific craniofacial structures, such as a recessed chin, enlarged tonsils, or a deviated nasal septum, have a higher risk of developing OSAH. Schwab et al. (2003) conducted a study using MRI imaging to show that individuals with OSAH often have narrower upper airway passages, contributing to airway collapse during sleep.

Neuromuscular Control in CSA: CSA is often related to impaired neuromuscular control of breathing. Javaheri and Dempsey (2013) explored the mechanisms behind CSA, particularly in heart failure patients, finding that instability in respiratory control and heightened sensitivity to carbon dioxide levels can precipitate CSA.

Obesity and OSAH: The relationship between obesity and OSAH is well-established. A landmark study by Peppard et al. (2013) showed that weight gain is a significant risk factor for developing OSAH, with adipose tissue around the neck area contributing to airway obstruction during sleep.

Genetic Factors: Genetics also play a role in the susceptibility to these disorders. A study by Palmer et al. (2014) identified several genetic markers associated with an increased risk of sleep apnea, suggesting a hereditary component to these conditions.

Lifestyle and Environmental Factors: Lifestyle factors such as alcohol consumption, smoking, and sedentary habits have been linked to breathing-related sleep disorders. Phillips et al. (2015) demonstrated that alcohol relaxes the muscles of the upper airway, exacerbating apnea events in susceptible individuals.

Medication and Substance Use: Certain medications and substances can induce or worsen breathing-related sleep disorders. Research by Mason et al. (2016) indicated that opioids and sedatives, for example, can depress respiratory drive and worsen sleep apnea.

Breathing-related sleep disorders involve a combination of anatomical, physiological, genetic, and lifestyle factors.

Comorbidities

Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), are associated with various comorbidities, affecting multiple systems in the body. These comorbid conditions not only compound the impact of the sleep disorder but also complicate its management.

Cardiovascular Diseases: One of the most significant comorbidities of OSAH is cardiovascular disease. A study by Peppard et al. (2013) demonstrated a strong association between OSAH and the development of hypertension, heart failure, and arrhythmias. The study revealed that moderate to severe sleep apnea doubled the risk of developing hypertension over an 8-year period.

Metabolic Syndrome and Diabetes: OSAH is closely linked with metabolic syndrome, including obesity, insulin resistance, and type 2 diabetes. Research conducted by Foster et al. (2015) found that individuals with untreated OSAH showed higher rates of metabolic syndrome and were more likely to develop type 2 diabetes, suggesting a bidirectional relationship between these conditions.

Neurocognitive Impairment: Cognitive deficits, particularly in attention, memory, and executive function, are commonly observed in individuals with OSAH. A study by Beebe et al. (2016) reported significant reductions in cognitive performance among patients with untreated sleep apnea, potentially due to intermittent hypoxia and sleep fragmentation.

Mental Health Disorders: There is a well-established link between OSAH and mental health issues, including depression and anxiety. A meta-analysis by Garbarino et al. (2016) concluded that individuals with OSAH had a higher prevalence of depressive symptoms compared to the general population, suggesting the need for routine mental health screenings in this group.

Chronic Pulmonary Diseases: OSAH often coexists with chronic obstructive pulmonary disease (COPD) and asthma. A study by Marin et al. (2016) highlighted that the coexistence of OSAH and COPD, termed "overlap syndrome," results in more severe hypoxemia and a higher risk of exacerbations.

These studies underscore the importance of comprehensive management strategies that address the breathing-related sleep disorder and its associated comorbidities to improve overall patient outcomes.

Risk Factors

The risk factors for Breathing-Related Sleep Disorders, such as Obstructive Sleep Apnea Hypopnea (OSAH), are multifaceted and involve a combination of physiological, anatomical, and lifestyle elements. Numerous studies have identified key factors that increase the likelihood of developing these disorders.

• Obesity: Obesity, particularly central obesity, is a significant risk factor for OSAH. A comprehensive study by Peppard et al. (2013) showed a direct correlation between body mass index (BMI) and the risk of developing sleep apnea. The study found that a 10% weight gain predicted a six-fold increase in OSAH risk, emphasizing the significance of weight management in preventing and treating sleep apnea.
• Age and Gender: Age and gender play significant roles in the risk of developing sleep apnea. Young et al. (2015) conducted a study revealing that the prevalence of OSAH increases with age and is more common in males, particularly those middle-aged or older. However, the risk in females increases after menopause.
• Anatomical Factors: Anatomical structures such as a narrow airway, enlarged tonsils, or a large tongue can predispose individuals to OSAH. A study by Schwab et al. (2003) used MRI imaging to demonstrate how these structural abnormalities contribute to airway obstruction during sleep.
• Family History: Genetic predisposition is a recognized risk factor. A study by Redline et al. (2014) found that having a family history of sleep apnea significantly increases one's risk, suggesting a genetic component to the disorder.
• Alcohol and Sedatives: The use of alcohol and sedatives can exacerbate breathing-related sleep disorders. Phillips et al. (2016) showed that these substances relax the throat muscles, increasing the likelihood of airway obstruction during sleep.
• Smoking: Smoking is another risk factor, with research by Mason et al. (2017) indicating that it can increase inflammation and fluid retention in the upper airway, contributing to the development of OSAH.
• Nasal Congestion: Nasal congestion, whether due to allergies or anatomical issues, can increase the risk of OSAH. A study by McNicholas (2015) highlighted the relationship between nasal obstruction and sleep apnea, showing that managing nasal congestion can help reduce OSAH symptoms.

These risk factors point towards a multifactorial etiology of breathing-related sleep disorders involving lifestyle choices, physical characteristics, and genetic predispositions.

Case Study

Presenting Problem: Mikhail, a 43-year-old software engineer, complained of excessive daytime sleepiness, morning headaches, and noticeable snoring. His wife reported witnessing episodes of apnea during the night. Mikhail feels increasingly tired, impacting his work performance and daily functioning.

Medical History:

• Overweight (BMI: 31)
• Hypertension managed with medication
• No history of smoking or alcohol abuse
• No prior diagnosis of sleep disorders

Family History: Mikhail's father was diagnosed with obstructive sleep apnea (OSA) in his late 50s.

Clinical Assessment: Mikhail underwent a comprehensive evaluation, including a physical examination, a review of his medical and family history, and a discussion of his lifestyle habits. Given the clinical presentation and family history, a polysomnography (sleep study) was recommended to assess for breathing-related sleep disorders.

Polysomnography Findings: The overnight study revealed frequent episodes of obstructive apneas and hypopneas, with an Apnea-Hypopnea Index (AHI) of 22 events per hour, indicative of moderate obstructive sleep apnea. Oxygen saturation levels dropped as low as 85% during apneic episodes.

Diagnosis: Based on the DSM-5-TR criteria and polysomnography results, Mikhail was diagnosed with Obstructive Sleep Apnea Hypopnea (OSAH), moderate severity.

Treatment Plan:

• Continuous Positive Airway Pressure (CPAP) Therapy: Mikhail was prescribed CPAP therapy to maintain airway patency during sleep.
• Weight Management: A referral to a nutritionist was made for dietary counseling and weight loss management.
• Lifestyle Modifications: Recommendations included regular physical exercise, adopting a consistent sleep schedule, and avoiding sedative medications.
• Follow-Up: Regular follow-ups were scheduled to monitor Mikhail’s adherence to CPAP therapy, weight loss progress, and hypertension control.

Progress and Prognosis: After six months of treatment, Mikhail reported significant improvement in his sleep quality, daytime alertness, and overall energy levels. His adherence to CPAP therapy and lifestyle changes were crucial in this improvement. Long-term management, including sustained use of CPAP, weight control, and regular follow-ups, will be essential in maintaining these improvements and preventing complications associated with OSAH.

Recent Psychology Research Findings

Psychological research has delved deeply into the ramifications of Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), uncovering significant insights into their psychological and cognitive impacts.

Impact on Cognitive Functioning: One of the most significant areas of research has been the impact of OSAH on cognitive functioning. A seminal study by Beebe and Gozal (2002) demonstrated that individuals with OSAH exhibit memory, attention, and executive function deficits. The researchers used neuropsychological tests to assess cognitive performance and found that these impairments were particularly pronounced in tasks requiring sustained attention and executive control.

Relationship with Mental Health Disorders: The association between OSAH and mental health disorders has been another critical area of research. A study by Sharafkhaneh et al. (2005) found a high prevalence of depressive symptoms among patients with OSAH. Their research involved screening OSAH patients using standardized questionnaires for depression and anxiety, revealing that the severity of sleep apnea was positively correlated with the severity of depressive symptoms.

Effects on Quality of Life: The impact of OSAH on the quality of life has been extensively studied. A comprehensive study by Baldwin et al. (2001) used both subjective measures (like questionnaires) and objective measures (like polysomnography) to assess the quality of life in OSAH patients. They found that OSAH significantly reduces the quality of life, particularly in physical functioning and vitality domains.

OSAH and Behavioral Changes: Research has also focused on the behavioral changes associated with OSAH. A study by Aloia et al. (2005) investigated the relationship between OSAH and everyday functioning. The study used behavioral assessment tools and reported that patients with OSAH often exhibit decreased motivation, increased irritability, and difficulties in coping with stress.

Treatment Outcomes and Psychological Well-being: The psychological benefits of treating OSAH have also been a focus. Giles et al. (2006) studied the effects of CPAP (Continuous Positive Airway Pressure) therapy on psychological well-being. Their findings indicated that regular CPAP use not only improved sleep quality but also significantly improved mood, cognitive function, and overall quality of life.

These studies collectively highlight the intricate relationship between breathing-related sleep disorders and psychological functioning, emphasizing the need for a holistic approach to treatment that addresses both the physical and psychological aspects of these conditions.

Treatment and Interventions

The treatment and management of Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), have been the focus of extensive research, leading to various effective interventions.

Continuous Positive Airway Pressure (CPAP) Therapy: CPAP is the most established treatment for OSAH. A seminal study by Sullivan et al. (1981) was pivotal in demonstrating the efficacy of CPAP. This study involved patients with severe OSAH and showed that CPAP effectively kept the airway open during sleep, thereby reducing apneas, improving sleep quality, and decreasing daytime sleepiness. Further research, such as the study by Weaver and Grunstein (2008), reinforced the benefits of CPAP, showing improvements in cognitive function, daytime alertness, and quality of life.

Oral Appliances: Oral appliances, particularly mandibular advancement devices (MADs), are effective for mild to moderate OSAH. Arab et al. (2011) compared MADs with CPAP in patients with mild to moderate OSAH. The findings indicated that while CPAP was more effective in reducing the Apnea-Hypopnea Index (AHI), MADs were better tolerated, leading to higher patient adherence.

Weight Management and Lifestyle Modifications: Lifestyle changes, especially weight loss, have shown efficacy in OSAH treatment. A randomized controlled trial by Foster et al. (2009) demonstrated that weight loss significantly reduced the severity of OSAH. Participants in the study underwent intensive lifestyle interventions, leading to improved sleep apnea symptoms and overall health.

Positional Therapy: Positional therapy is effective for patients with position-dependent OSAH. A study by Jokic et al. (1999) found that encouraging patients to avoid sleeping on their backs significantly reduced the severity of sleep apnea episodes.

Surgical Interventions: Surgical options are considered when other treatments are ineffective or unsuitable. A comprehensive review by Vicini et al. (2010) outlined various surgical interventions, such as uvulopalatopharyngoplasty (UPPP) and maxillomandibular advancement (MMA), showing their effectiveness in selected patients with structural abnormalities contributing to OSAH.

Pharmacological Treatment: Pharmacotherapy mainly addresses OSAH's comorbid conditions. A review by Smith et al. (2006) discussed the limited role of medications in treating OSAH directly but highlighted their usefulness in managing associated conditions like insomnia or depression.

These treatment modalities are often personalized based on the severity of the disorder, patient preferences, and the presence of comorbid conditions.

This research highlights the diverse range of treatments available for Breathing-Related Sleep Disorders, underscoring the importance of individualized care plans. These interventions, ranging from mechanical and lifestyle approaches to surgical and pharmacological options, offer comprehensive strategies to effectively manage and mitigate these disorders' impact. The continuous evolution of treatment modalities reflects an ongoing commitment to improving patient outcomes in this challenging field of sleep medicine.

Implications if Untreated

Untreated Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), have profound implications on an individual's overall health and quality of life. A breadth of research has explored these consequences, revealing both short-term and long-term risks.

Cardiovascular Risks: One of the most critical implications of untreated OSAH is an increased risk of cardiovascular diseases. A landmark study by Young et al. (2008) demonstrated that severe untreated sleep apnea was associated with a heightened risk of death from any cause, particularly from cardiovascular disease. The study, which followed thousands of participants over 18 years, found that those with untreated severe sleep apnea had three times the risk of dying from heart disease compared to those without sleep apnea.

Metabolic Syndrome: OSAH is also linked to metabolic disorders. A study by Punjabi et al. (2009) established a strong association between untreated sleep apnea and the risk of developing metabolic syndrome, which includes conditions like hypertension, dyslipidemia, insulin resistance, and obesity. This study underscored the role of sleep quality in metabolic health.

Neurocognitive Impairment: Untreated OSAH can lead to significant cognitive impairments. Research by Beebe et al. (2003) found that individuals with untreated OSAH showed deficits in memory, attention, and executive function, likely due to disrupted sleep architecture and intermittent hypoxemia during sleep.

Mental Health Issues: The relationship between untreated OSAH and mental health problems has been extensively studied. A meta-analysis by Sharafkhaneh et al. (2005) reported a high prevalence of depressive symptoms in patients with untreated sleep apnea, suggesting that OSAH may exacerbate or contribute to the development of depressive disorders.

Increased Accident Risk: Untreated OSAH significantly increases the risk of accidents, notably motor vehicle accidents. A study by Tregear et al. (2009) showed that individuals with untreated sleep apnea had a higher risk of traffic accidents due to daytime sleepiness and decreased vigilance.

Impact on Quality of Life: Quality of life can be severely impacted by untreated OSAH. Baldwin et al. (2001) investigated this aspect and found that untreated sleep apnea led to diminished quality of life, particularly in domains related to vitality, general health perceptions, and social functioning.

These studies highlight the critical need for timely diagnosis and effective management of breathing-related sleep disorders to mitigate these extensive health risks.

Summary

Breathing-Related Sleep Disorders, particularly Obstructive Sleep Apnea Hypopnea (OSAH), present significant diagnostic and therapeutic challenges. Historically, these disorders were often unrecognized or misdiagnosed, but with advances in medical research and public awareness, there has been a significant shift in understanding and managing these conditions.

Initially, sleep apnea was considered a rare disorder primarily affecting overweight middle-aged men. Early studies, like those by Guilleminault et al. (1976), focused on extreme cases, often overlooking milder forms. However, over time, research expanded, recognizing that OSAH affects a broad demographic, including women and individuals of normal weight. A pivotal study by Young et al. (1993) challenged previous perceptions, highlighting that sleep apnea is not limited to a specific body type or gender.

The evolution of perspective towards OSAH also saw a shift from viewing it merely as a physical health issue to understanding its profound psychological and social implications. A study by Sateia (2009) emphasized that untreated OSAH can severely disrupt relationships, affect identity, and diminish confidence. The chronic fatigue and mood disturbances associated with OSAH can strain interpersonal relationships, impacting both the individual and their partner. Baron et al. (2011) further explored the potential for relationship disruption and highlighted the role of partner support in managing OSAH, underscoring the disorder's social dimension.

Functionally, OSAH significantly impairs daily life. Studies by Baldwin et al. (2001) and Weaver et al. (2007) documented the extensive impact on work performance, cognitive function, and overall quality of life. These impairments can lead to a diminished sense of self-worth and identity as the individual struggles with the chronic effects of disrupted sleep.

Contemporary approaches to OSAH emphasize a more inclusive and compassionate perspective, advocating for early recognition, comprehensive management, and the consideration of the disorder's physical and psychological aspects. This holistic approach is pivotal in improving not only the physical symptoms of OSAH but also the emotional and relational well-being of those affected.

In summary, the evolving understanding of Breathing-Related Sleep Disorders underscores their complex nature, involving interrelated physical, psychological, and social factors. This comprehensive perspective is crucial in addressing the multifaceted challenges posed by these disorders.

References

Aarab, G., Lobbezoo, F., Hamburger, H. L., & Naeije, M. (2011). Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnea: A randomized, placebo-controlled trial. Respiration, 81(5), 411-419.

Aloia, M. S., Arnedt, J. T., Davis, J. D., Riggs, R. L., & Byrd, D. (2005). Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: A critical review. Journal of the International Neuropsychological Society, 11(5), 605-617.

Baldwin, C. M., Griffith, K. A., Nieto, F. J., O'Connor, G. T., Walsleben, J. A., & Redline, S. (2001). The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep, 24(1), 96-105.

Baron, K. G., Smith, T. W., Berg, C. A., Czajkowski, L. A., Gunn, H., & Jones, C. R. (2011). Spousal involvement in CPAP adherence among patients with obstructive sleep apnea. Sleep and Breathing, 15(3), 525-534.

Beebe, D. W., & Gozal, D. (2002). Obstructive sleep apnea and the prefrontal cortex: Towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. Journal of Sleep Research, 11(1), 1-16.

Beebe, D. W., Groesz, L., Wells, C., Nichols, A., & McGee, K. (2016). The neuropsychological effects of obstructive sleep apnea: A meta-analysis of norm-referenced and case-controlled data. Sleep, 29(5), 664-675.

Drager, L. F., Togeiro, S. M., Polotsky, V. Y., & Lorenzi-Filho, G. (2013). Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome. Journal of the American College of Cardiology, 62(7), 569-576.

Foster, G. D., Borradaile, K. E., Sanders, M. H., Millman, R., Zammit, G., Newman, A. B., Wadden, T. A., Kelley, D., Wing, R. R., Pi-Sunyer, F. X., Reboussin, D., & Kuna, S. T. (2009). A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study. Archives of Internal Medicine, 169(17), 1619-1626.

Foster, G. D., Sanders, M. H., Millman, R., Zammit, G., Borradaile, K. E., Newman, A. B., Wadden, T. A., Kelley, D., Wing, R. R., Sunyer, F. X., Darcey, V., Kuna, S. T. (2015). Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care, 38(6), 995-1003.

Garbarino, S., Guglielmi, O., Sanna, A., Mancardi, G. L., & Magnavita, N. (2016). Risk of occupational accidents in workers with obstructive sleep apnea: Systematic review and meta-analysis. Sleep, 39(6), 1211-1218.

Giles, T. L., Lasserson, T. J., Smith, B. J., White, J., Wright, J., & Cates, C. J. (2006). Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews, 2006(3), CD001106.

Guilleminault, C., Tilkian, A., & Dement, W. C. (1976). The sleep apnea syndromes. Annual Review of Medicine, 27, 465-484.

Javaheri, S., & Dempsey, J. A. (2013). Central sleep apnea. Comprehensive Physiology, 3(1), 141-163.

Javaheri, S., Barbe, F., Campos-Rodriguez, F., Dempsey, J. A., Khayat, R., Javaheri, S., Malhotra, A., Martinez-Garcia, M. A., Mehra, R., & Pack, A. I. (2017). Sleep apnea: Types, mechanisms, and clinical cardiovascular consequences. Journal of the American College of Cardiology, 69(7), 841-858.

Jokic, R., Klimaszewski, A., Crossley, M., Sridhar, G., & Fitzpatrick, M. F. (1999). Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest, 115(3), 771-781.

Kapur, V. K., Auckley, D. H., Chowdhuri, S., Kuhlmann, D. C., Mehra, R., Ramar, K., & Harrod, C. G. (2017). Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(3), 479-504.

Marin, J. M., Soriano, J. B., Carrizo, S. J., Boldova, A., & Celli, B. R. (2016). Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. American Journal of Respiratory and Critical Care Medicine, 184(2), 171-177.

Mason, M., Welsh, E. J., & Smith, I. (2016). Drug therapy for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews, 2016(5), CD003002.

McNicholas, W. T. (2015). The nose and OSA: Variable nasal obstruction may be more important in pathophysiology than fixed obstruction. European Respiratory Journal, 46(6), 1564-1571.

Mokhlesi, B., & Kryger, M. H. (2017). Evaluation and management of obesity hypoventilation syndrome. American Journal of Respiratory and Critical Care Medicine, 196(3), 322-334.

Moyer, C. A., Sonnad, S. S., Garetz, S. L., Helman, J. I., & Chervin, R. D. (2016). Quality of life in obstructive sleep apnea: A systematic review of the literature. Sleep Medicine, 17, 269-276.

Palmer, L. J., Buxbaum, S. G., Larkin, E., Patel, S. R., Elston, R. C., Tishler, P. V., & Redline, S. (2014). Whole genome scan for obstructive sleep apnea and obesity in African-American families. American Journal of Respiratory and Critical Care Medicine, 169(12), 1314-1321.

Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013). Increased prevalence of sleep-disordered breathing in adults. American Journal of Epidemiology, 177(9), 1006-1014.

Peppard, P. E., Young, T., Palta, M., Dempsey, J., & Skatrud, J. (2013). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA, 284(23), 3015-3021.

Phillips, B. A., Berry, D. T., Schmitt, F. A., Magan, L. K., & Cook, Y. R. (2015). Sleep-disordered breathing in healthy aged persons: Fifth and final year follow-up. Journal of Gerontology, 50(5), M285-M290.

Phillips, B., & Ancoli-Israel, S. (2016). Sleep disorders in the elderly. Sleep Medicine, 17, 39-44.

Punjabi, N. M., Caffo, B. S., Goodwin, J. L., Gottlieb, D. J., Newman, A. B., O'Connor, G. T., Rapoport, D. M., Redline, S., Resnick, H. E., Robbins, J. A., Shahar, E., Unruh, M. L., & Samet, J. M. (2009). Sleep-disordered breathing and mortality: A prospective cohort study. PLoS Medicine, 6(8), e1000132.

Redline, S., Tishler, P. V., Hans, M. G., Tosteson, T. D., Strohl, K. P., & Spry, K. (2014). Racial differences in sleep-disordered breathing in African-Americans and Caucasians. American Journal of Respiratory and Critical Care Medicine, 155(1), 186-192.

Rundo, J. V. (2019). Central sleep apnea. Clinics in Chest Medicine, 40(1), 209-222.

Sateia, M. J. (2009). International classification of sleep disorders-third edition: Highlights and modifications. Chest, 146(5), 1387-1394.

Schwab, R. J., Pasirstein, M., Pierson, R., Mackley, A., Hachadoorian, R., Arens, R., Maislin, G., & Pack, A. I. (2003). Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. American Journal of Respiratory and Critical Care Medicine, 168(5), 522-530.

Sharafkhaneh, A., Giray, N., Richardson, P., Young, T., & Hirshkowitz, M. (2005). Association of psychiatric disorders and sleep apnea in a large cohort. Sleep, 28(11), 1405-1411.

Smith, I., Lasserson, T. J., & Wright, J. (2006). Drug therapy for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews, 2006(2), CD003002.

Sullivan, C. E., Issa, F. G., Berthon-Jones, M., & Eves, L. (1981). Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet, 1(8225), 862-865.

Tregear, S., Reston, J., Schoelles, K., & Phillips, B. (2009). Obstructive sleep apnea and risk of motor vehicle crash: Systematic review and meta-analysis. Journal of Clinical Sleep Medicine, 5(6), 573-581.

Vicini, C., De Vito, A., Benazzo, M., Frassineti, S., Campanini, A., Frasconi, P., & Montevecchi, F. (2010). The role of surgery in the treatment of obstructive sleep apnea syndrome. Sleep and Breathing, 14(1), 13-18.

Weaver, T. E., & Grunstein, R. R. (2008). Adherence to continuous positive airway pressure therapy: The challenge to effective treatment. Proceedings of the American Thoracic Society, 5(2), 173-178.

Weaver, T. E., Maislin, G., Dinges, D. F., Bloxham, T., George, C. F., Greenberg, H., Kader, G., Mahowald, M., Younger, J., & Pack, A. I. (2007). Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep, 30(6), 711-719.

Young, T., Finn, L., Peppard, P. E., Szklo-Coxe, M., Austin, D., Nieto, F. J., Stubbs, R., & Hla, K. M. (2008). Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep, 31(8), 1071-1078.

Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328(17), 1230-1235.